China has more than 200 million hypertensive patients, according to Ma Xiaowei, an official at the National Health and Family Planning Commission of China.
CDFA (“CDE”) has accepted and processed a total of 4,551 new drug applications (calculated by the process number) in the first half of 2014, achieving a historical high.
Public data indicated that from 2015 to 2018, patented drugs around the world will enter an intensive phase of patent expiration
China’s import of biochemical drugs achieved a 6.13 percent year-on-year increase to a record high of USD 2.397 billion in 2013.
In 2014, the global economy is dividing as Europe and the United States continue to recover while the emerging economies shrink
Starting from July 1, 2014, the retail cap for 181 low priced drugs is going to be removed in Jiangsu Province.